290 related articles for article (PubMed ID: 27639683)
1. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.
Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R
J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
3. Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model.
Erdogan M; Wright JR; McAlister VC
Br J Dermatol; 2002 Jun; 146(6):964-7. PubMed ID: 12072063
[TBL] [Abstract][Full Text] [Related]
4. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P.
Lee SG; Kang JB; Kim SR; Kim CJ; Yeom DW; Yoon HY; Kwak SS; Choi YW
Drug Dev Ind Pharm; 2016 Oct; 42(10):1636-42. PubMed ID: 26925849
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.
Jain A; Doppalapudi S; Domb AJ; Khan W
J Control Release; 2016 Dec; 243():132-145. PubMed ID: 27725194
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
[TBL] [Abstract][Full Text] [Related]
7. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
8. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
[TBL] [Abstract][Full Text] [Related]
9. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
10. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
Kaur N; Sharma K; Bedi N
Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
[TBL] [Abstract][Full Text] [Related]
11. How Effective Is Tacrolimus in the Imiquimod-Induced Mouse Model of Psoriasis?
Pischon H; Radbruch M; Ostrowski A; Schumacher F; Hönzke S; Kleuser B; Hedtrich S; Fluhr JW; Gruber AD; Mundhenk L
J Invest Dermatol; 2018 Feb; 138(2):455-458. PubMed ID: 28947356
[No Abstract] [Full Text] [Related]
12. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
13. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
Amarji B; Garg NK; Singh B; Katare OP
J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Biodistribution of Tacrolimus after Topical Administration: Implications for Vascularized Composite Allotransplantation.
Feturi FG; Schnider JT; Fanzio PM; Erbas VE; Oksuz S; Sahin H; Dong L; Unadkat JM; Spiess AM; Plock JA; Solari MG; Gorantla VS; Venkataramanan R
Pharm Res; 2020 Oct; 37(11):222. PubMed ID: 33067715
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable core-multishell nanocarrier: Topical tacrolimus delivery for treatment of dermatitis.
Radbruch M; Pischon H; Du F; Haag R; Schumacher F; Kleuser B; Mundhenk L; Gruber AD
J Control Release; 2022 Sep; 349():917-928. PubMed ID: 35905785
[TBL] [Abstract][Full Text] [Related]
16. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
Fries CA; Lawson SD; Wang LC; Slaughter KV; Vemula PK; Dhayani A; Joshi N; Karp JM; Rickard RF; Gorantla VS; Davis MR
PLoS One; 2019; 14(1):e0210914. PubMed ID: 30677062
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation.
Thapa RK; Yoo BK
J Dermatolog Treat; 2014 Feb; 25(1):22-5. PubMed ID: 23210668
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation.
Li G; Fan Y; Fan C; Li X; Wang X; Li M; Liu Y
Eur J Pharm Biopharm; 2012 Sep; 82(1):49-57. PubMed ID: 22705640
[TBL] [Abstract][Full Text] [Related]
19. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug.
Doppalapudi S; Jain A; Khan W; Domb AJ
Int J Pharm; 2020 Jan; 573():118726. PubMed ID: 31715365
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
